Peripheral blood gene expression profiling shows prognostic significance for the course of interstitial lung disease in systemic sclerosis

Journal:

Arthritis & Rheumatology

Published:

2025-05-28

DOI:

10.1002/art.43262

Affiliations:

4

Authors:

7

Go to article

Institutions	Authors	Share
Boehringer Ingelheim Pharma GmbH & Co. KG, Germany	4.000000	0.57
Boehringer Ingelheim Pharmaceuticals, Inc., United States of America (USA)	1.000000	0.14
UCL, United Kingdom (UK)	1.000000	0.14
The University of Texas Health Science Center at Houston (UTHealth), United States of America (USA)	1.000000	0.14

Interested in Clinical Sciences?